C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer

• Published in: Oncogene Vol. 39; no. 13; pp. 2724 - 2740
• Main Authors: Lee, Po-Chu, Chen, Syue-Ting, Kuo, Ting-Chun, Lin, Tzu-Chi, Lin, Mei-Chun, Huang, John, Hung, Ji-Shiang, Hsu, Chia-Lang, Juan, Hsueh-Fen, Lee, Po-Huang, Huang, Min-Chuan
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 26-03-2020; Nature Publishing Group
• Subjects: 13/105; 13/89; 38/39; 5-Fluorouracil; 631/67/1504/1829; 631/80/86/2368; 64/60; 82/1; 82/29; 82/51; 82/80; 96/109; 96/31; 96/95; Acetylgalactosamine - metabolism; Adenocarcinoma - genetics; Adenocarcinoma - mortality; Adenocarcinoma - pathology; Adenocarcinoma - surgery; Animals; Apoptosis; Care and treatment; Cell activation; Cell adhesion & migration; Cell Biology; Cell Line, Tumor; Cell migration; Cell Movement - genetics; Cell Survival - genetics; Cell viability; Cytotoxicity; Development and progression; Enzymes; Eph protein; EphA2 protein; Ephrin-A1 - metabolism; Ephrin-A2 - metabolism; Galactosyltransferases - genetics; Galactosyltransferases - metabolism; Gastric cancer; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Knockout Techniques; Genetic aspects; Glycosylation; Glycosyltransferases; Health aspects; Human Genetics; Humans; Internal Medicine; Invasiveness; Kaplan-Meier Estimate; Male; Medicine; Medicine & Public Health; Metastases; Mice; Mutants; Neoplasm Staging; Oncology; Phosphorylation; Polysaccharides; Protein kinases; Regulation; Stomach - pathology; Stomach - surgery; Stomach cancer; Stomach Neoplasms - genetics; Stomach Neoplasms - mortality; Stomach Neoplasms - pathology; Stomach Neoplasms - surgery; Therapeutic applications; Therapeutic targets; Tyrosine; Xenograft Model Antitumor Assays; Taiwan
• DOI: 10.1038/s41388-020-1178-7
• EISSN: 1476-5594
• ISSN: 0950-9232

C1GALT1 controls the crucial step of GalNAc-type O-glycosylation and is associated with both physiologic and pathologic conditions, including cancers. EPH receptors comprise the largest family of receptor tyrosine kinases (RTKs) and modulate a diverse range of developmental processes and human diseases. However, the role of C1GALT1 in the signaling of EPH receptors remains largely overlooked. Here, we showed that C1GALT1 high expression in gastric adenocarcinomas correlated with adverse clinicopathologic features and is an independent prognostic factor for poor overall survival. Silencing or loss of C1GALT1 inhibited cell viability, migration, invasion, tumor growth and metastasis, as well as increased apoptosis and cytotoxicity of 5-fluorouracil in AGS and MKN45 cells. Phospho-RTK array and western blot analysis showed that C1GALT1 depletion suppressed tyrosine phosphorylation of EPHA2 induced by soluble Ephrin A1-Fc. O-glycans on EPHA2 were modified by C1GALT1 and both S277A and T429A mutants, which are O-glycosites on EPHA2, dramatically enhanced phosphorylation of Y588, suggesting that not only overall O-glycan structures but also site-specific O-glycosylation can regulate EPHA2 activity. Furthermore, depletion of C1GALT1 decreased Ephrin A1-Fc induced migration and reduced Ephrin A1 binding to cell surfaces. The effects of C1GALT1 knockdown or knockout on cell invasiveness in vitro and in vivo were phenocopied by EPHA2 knockdown in gastric cancer cells. These results suggest that C1GALT1 promotes phosphorylation of EPHA2 and enhances soluble Ephrin A1-mediated migration primarily by modifying EPHA2 O-glycosylation. Our study highlights the importance of GalNAc-type O-glycosylation in EPH receptor-regulated diseases and identifies C1GALT1 as a potential therapeutic target for gastric cancer.